SEC Form 4 · accession 0001354488-17-000513
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Cook
Officer — Chief Financial Officer
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2017 | P | 50,000 | $0.499 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $1.69 | holding | — | — | — | — | Jan 30, 2027 | Common Stock | 165,000 | 165,000 | D |
| Stock Option (Right to Buy Common Stock)F2 | $1.69 | holding | — | — | — | — | Jan 30, 2027 | Common Stock | 185,000 | 185,000 | D |
Explanation of responses
- F1The option vests based on certain performance milestones. The option will be forfeited if such milestones are not met by certain dates.
- F2The option vests in four equal annual installments beginning on the first anniversary of the vesting commencement date, 2/1/18, subject to continued employment.